Logo
GM1 GANGLIOSIDOSIS TREATMENT MARKET ANALYSIS
  2. / Market Insights
  3. Gm1 Gangliosidosis Treatment Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

GM1 GANGLIOSIDOSIS TREATMENT MARKET ANALYSIS

GM1 Gangliosidosis Treatment Market, by Product Type (LYS-GM101, PBGM01, AXO-AAV-GM1), by Disease Type (Type 1 GM1 Gangliosidosis, Type 2 GM1 Gangliosidosis, and Type 3 GM1 Gangliosidosis), and by Region (North America,  Europe and Rest of World ) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2030

  • Published In : Nov 2020
  • Code : CMI4270
  • Pages :101
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Key Players

Major players operating in the global GM1 Gangliosidosis Treatment market are Axovant Gene Therapies Ltd. and Passage Bio and Lysogene.

Companies covered:

Axovant Gene Therapies Ltd, Passage Bio and Lysogene.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

GM1 Gangliosidosis Treatment Market to Surpass US$ 651.7 Million by 2030
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.